Regulation of angiogenesis by scatter factor

Area of Science:

• Cell Biology
• Molecular Biology
• Oncology

Background:

• Scatter factor (SF), also known as hepatocyte growth factor, is a cytokine involved in cell motility, proliferation, and morphogenesis.
• SF signals through its tyrosine kinase receptor, c-met, encoded by a proto-oncogene.
• SF is a potent angiogenic molecule, stimulating endothelial cell proliferation, motility, invasion, and tube formation.

Purpose of the Study:

• To investigate the role of Scatter factor (SF) and its receptor c-met in tumor angiogenesis.
• To explore the hypothesis that tumor suppressor gene mutations activate the SF-c-met pathway, promoting an invasive and angiogenic tumor phenotype.
• To assess the potential of modulating the SF-c-met pathway for therapeutic interventions in cancer.

Main Methods:

• Review of existing literature on Scatter factor (SF), c-met signaling, and angiogenesis.
• Analysis of proposed mechanisms linking tumor suppressor genes to SF-c-met pathway activation.
• Discussion of the implications for cancer therapy.

Main Results:

• SF directly stimulates endothelial cells, promoting key steps in angiogenesis.
• SF also stimulates proliferation of smooth muscle cells and pericytes, contributing to microvessel formation.
• SF is overexpressed in tumors, suggesting a role as a tumor angiogenesis factor, potentially driven by tumor-stroma interactions or autocrine production.

Conclusions:

• The SF-c-met signaling pathway plays a critical role in tumor angiogenesis and invasion.
• Mutations in tumor suppressor genes may lead to the activation of this pathway, contributing to malignancy.
• Targeting the SF-c-met pathway presents a promising therapeutic strategy for controlling tumor growth and metastasis.